Machine learning models using patient-reported outcomes, wearables, and clinical data accurately predicted urgent care visits ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...
Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.
A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed collaboration with Guardant Health, Inc. (Nasdaq: GH), ...
Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...